Cardiomyocyte PKA ablation eliminates cardiac β-adrenergic response without adverse effects on the heart
Ying Zhang,Xiaoying Zhang,Ying Li,Wei Wang,Biyi Chen,Chong Liu,Xiaojie Ai,Xiaoxiao Zhang,Ying Tian,Chen Zhang,Mingxin Tang,Christopher Szeto,Xiang Hua,Mingxin Xie,Chunyu Zeng,Yingjie Wu,Lin Zhou,Steven Houser,Xiongwen Chen
DOI: https://doi.org/10.1016/j.yjmcc.2019.11.059
IF: 5.763
2020-01-01
Journal of Molecular and Cellular Cardiology
Abstract:Rationale:Protein Kinase A (PKA) is a major mediator of β-adrenergic (βAR) regulation of cardiac function but other mediators have also been suggested. Reduced PKA basal activity and activation are linked to cardiac diseases. However, how complete loss of PKA activity impacts on cardiac physiology and if it causes cardiac dysfunction have never been determined. Objectives: We set to determine how the heart adapts to the loss of cardiomyocyte PKA activity and if it elicits cardiac abnormalities. Methods and Results: (1) Cardiac PKA activity was almost completely inhibited by expressing a PKA inhibitor peptide in cardiomyocytes (cPKAi) in mice; (2) cPKAi reduced basal phosphorylation of two myofilament proteins (troponin I, cardiac myosin binding protein C), and one longitudinal SR protein (phospholamban), but not of the sarcolemmal proteins (Cav1.2 a1c, phospholemman), dyadic protein RyR2 and nuclear protein CREB at their PKA phosphorylation sites; (3) cPKAi increased the expression of CaMKII, the Cav1.2 β subunits and current, but decreased CaMKII phosphorylation and CaMKII-mediated phosphorylation of phospholamban and RyR2; (4) These changes resulted in significantly enhanced myofilament Ca2+ sensitivity, prolonged contraction, slowed relaxation but increased myocyte Ca2+ transient and contraction amplitudes; (5) ISO-induced PKA and CaMKII activation and their phosphorylation of proteins were prevented by cPKAi; (6) cPKAi abolished the increases of heart rate, and cardiac and myocyte contractility by a β-adrenergic agonist (isoproterenol, ISO), showing an important role of PKA and a minimal role of PKA-independent βAR signaling in acute cardiac regulation; (7) cPKAi mice have partial exercise capability probably by enhancing vascular constriction and ventricular filling during βAR stimulation; (8) cPKAi mice did not show any cardiac functional or structural abnormalities during the 1-year age. Conclusion: PKA activity suppression induces a unique Ca2+ handling phenotype, eliminates βAR-regulation of heart rates and cardiac contractility, but without cardiac abnormalities.